In The News
Accordia Commemorates World TB Day
March 24, 2010, Washington DC: Today, Accordia Global Health Foundation joins the global health community in recognizing World Tuberculosis Day.
Each year, nearly 2 million people die of TB-related causes, and the disease is the leading killer of people with HIV. Despite the prevalence of the disease, healthcare workers are limited by dated and often ineffective diagnostic and treatment options. The only licensed vaccine against TB is more than 100 years old and does not prevent adult pulmonary (lung) TB, the most common and infectious form of the disease.
Accordia’s 2009 Global Health Leadership awardee and director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, recently discussed the importance of investing in tuberculosis research, stating:
“There are primitive diagnostics, drug regimens that are complex, that are not new, that really don’t work very well in many cases of multiple and extensively drug-resistant cases, and a vaccine that doesn’t work. Is there a research challenge here? [We have a] disease that’s centuries old, that kills 1.7 million people, and we have primitive counter measures against it.
“It is imperative that we use our current momentum to move forward, recognizing that the enormous challenges of global health…will require a long-term commitment that is sustained even when global health and those fighting to improve it are no longer in the headlines.” (Watch the full speech)
Accordia and its partners are focused on fulfilling this call to action and finding solutions that effectively prevent and treat tuberculosis. Accordia’s Academic Alliance members are leading research projects and clinical trials in Uganda and around the world, in search of more advanced and effective disease prevention, diagnosis, and management methods.
Accordia’s main implementing partner, the Infectious Diseases Institute in Kampala, Uganda, established a TB clinic in 2008 to improve diagnosis and treatment of patients co-infected with TB and HIV. Since its formation, the clinic has screened thousands of patients for tuberculosis and treated hundreds more. Tuberculosis management has become a cornerstone of IDI’s work to improve HIV/AIDS services in Kampala and throughout the rest of Uganda.
As millions of people around the world continue to suffer from tuberculosis, Accordia unites with the global health community, working toward innovative solutions through tuberculosis treatment, research, and training.